Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 3;17(1):47.
doi: 10.1186/s40246-023-00498-0.

Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility

Affiliations
Review

Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility

Kush Ketan Patel et al. Hum Genomics. .

Abstract

Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular disease (CVD) deaths in the USA and around the globe. Due to the complex nature, progression, inherent genetic makeup, and heterogeneity of CVDs, personalized treatments are believed to be critical. To improve the deciphering of CVD mechanisms, we need to deeply investigate well-known and identify novel genes that are responsible for CVD development. With the advancements in sequencing technologies, genomic data have been generated at an unprecedented pace to foster translational research. Correct application of bioinformatics using genomic data holds the potential to reveal the genetic underpinnings of various health conditions. It can help in the identification of causal variants for AF, HF, and other CVDs by moving beyond the one-gene one-disease model through the integration of common and rare variant association, the expressed genome, and characterization of comorbidities and phenotypic traits derived from the clinical information. In this study, we examined and discussed variable genomic approaches investigating genes associated with AF, HF, and other CVDs. We collected, reviewed, and compared high-quality scientific literature published between 2009 and 2022 and accessible through PubMed/NCBI. While selecting relevant literature, we mainly focused on identifying genomic approaches involving the integration of genomic data; analysis of common and rare genetic variants; metadata and phenotypic details; and multi-ethnic studies including individuals from ethnic minorities, and European, Asian, and American ancestries. We found 190 genes associated with AF and 26 genes linked to HF. Seven genes had implications in both AF and HF, which are SYNPO2L, TTN, MTSS1, SCN5A, PITX2, KLHL3, and AGAP5. We listed our conclusion, which include detailed information about genes and SNPs associated with AF and HF.

Keywords: Atrial fibrillation; Cardiovascular diseases; Genes; Genetic loci; Genomics; Heart failure; Multi-OMICS.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Genomics approaches for genetic loci discovery
Fig. 2
Fig. 2
Intersection of atrial fibrillation (AF) and heart failure (HF) genes and studies reporting. The bars of the upset plot represent the unique number of genes associated with each study, while the matrix below the bars highlights the intersectionality between different studies. Dots appear to be darker and linked to genes that are included in multiple studies. The bars next to the matrix represent the cardinality of each intersection
Fig. 3
Fig. 3
Overlapping between identified genes from different approaches for atrial fibrillation (AF) and heart failure (HF)

References

    1. Mc Namara K, Alzubaidi H, Jackson JK. Cardiovascular disease as a leading cause of death: How are pharmacists getting involved? Integr Pharm Res Pract. 2019;4(8):1–11. doi: 10.2147/IPRP.S133088.PMID:30788283;PMCID:PMC6366352. - DOI - PMC - PubMed
    1. Peters SAE, Muntner P, Woodward M. Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation. 2019;139(8):1025–1035. doi: 10.1161/CIRCULATIONAHA.118.035550. - DOI - PubMed
    1. Dickinson O, Chen LY, Francis GS. Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality. Heart Fail Rev. 2014;19(3):285–293. doi: 10.1007/s10741-013-9409-4. - DOI - PubMed
    1. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501–1517. doi: 10.1161/CIRCRESAHA.117.309732. - DOI - PMC - PubMed
    1. Kalogirou F, Forsyth F, Kyriakou M, Mantle R, Deaton C. Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction. ESC Heart Fail. 2020;7(1):194–212. doi: 10.1002/ehf2.12559. - DOI - PMC - PubMed

Publication types